VJHemOnc Podcast cover image

iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes

VJHemOnc Podcast

CHAPTER

Patient Eligibility and Challenges in Transplantation and Immunotherapies for AML

This chapter explores the patient population most suitable for transplantation and immunotherapies in AML, highlighting the exclusion of TP53 complex curio types and the challenges posed by the immunosuppressive microenvironment for CAR-T therapy. It proposes an innovative allergen egg type product and the importance of a tailored approach for this specific group.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner